Publication Name	World Journal of Diabetes
Manuscript ID	63360
Country	Canada

Received	2021-01-27 17:07
Peer-Review Started	2021-01-27 17:12
To Make the First Decision
Return for Revision	2021-02-25 01:14
Revised	2021-03-05 21:24
Second Decision	2021-04-12 08:41
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-04-14 17:06
Articles in Press	2021-04-14 17:06
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-04-21 23:17
Publish the Manuscript Online	2021-05-06 11:18

ISSN	1948-9358 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Review
Article Title	Recent advances in new-onset diabetes mellitus after kidney transplantation
Manuscript Source	Invited Manuscript
All Author List	Tess Montada-Atin and G V Ramesh Prasad
ORCID	Author(s) ORCID Number Tess Montada-Atin http://orcid.org/0000-0003-3701-2948 G V Ramesh Prasad http://orcid.org/0000-0003-1576-7696
Funding Agency and Grant Number
Corresponding Author	G V Ramesh Prasad, MBBS, PhD, Professor, Kidney Transplant Program, St. Michael's Hospital, 61 Queen Street East, 9th Floor, Toronto M5C 2T2, Ontario, Canada. ramesh.prasad@unityhealth.to
Key Words	Cardiovascular disease; Glucagon-like peptide-1 receptor agonists; Kidney transplantation; Oral antihyperglycemic drugs; Post-transplant diabetes mellitus; Sodium glucose co-transporter 2 inhibitors; Dipeptidyl peptidase-4 inhibitors
Core Tip	Kidney transplant recipients commonly develop post-transplant diabetes mellitus. Sodium glucose co-transporter 2 inhibitors, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase 4 inhibitors are now available for treating type 2 diabetes mellitus. There is increasing evidence that these classes of drugs are effective in kidney transplant recipients, but caution is still advised due to their increased propensity otherwise for intravascular volume depletion, infections, and reduced kidney function.
Publish Date	2021-05-06 11:18
Citation	Montada-Atin T, Prasad GVR. Recent advances in new-onset diabetes mellitus after kidney transplantation. World J Diabetes 2021; 12(5): 541-555
URL	https://www.wjgnet.com/1948-9358/full/v12/i5/541.htm
DOI	https://dx.doi.org/10.4239/wjd.v12.i5.541

Full Article (PDF)	WJD-12-541.pdf
Full Article (Word)	WJD-12-541.docx
Manuscript File	63360_Auto_Edited_LM.docx
Answering Reviewers	63360-Answering reviewers.pdf
Audio Core Tip	63360-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	63360-Conflict-of-interest statement.pdf
Copyright License Agreement	63360-Copyright license agreement.pdf
Peer-review Report	63360-Peer-review(s).pdf
Scientific Misconduct Check	63360-Scientific misconduct check.pdf
Scientific Editor Work List	63360-Scientific editor work list.pdf
CrossCheck Report	63360-CrossCheck report.pdf